XML 31 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Royalties    
Disaggregation of Revenue [Line Items]    
Total revenue $ 20,800  
Promacta    
Disaggregation of Revenue [Line Items]    
Total revenue 15,600  
Kyprolis    
Disaggregation of Revenue [Line Items]    
Total revenue 3,300  
Evomela    
Disaggregation of Revenue [Line Items]    
Total revenue 1,600  
Other    
Disaggregation of Revenue [Line Items]    
Total revenue 400  
Material Sales: Captisol    
Disaggregation of Revenue [Line Items]    
Total revenue 4,391 $ 1,121
License fees, milestones and other    
Disaggregation of Revenue [Line Items]    
Total revenue 30,946 3,916
License Fees    
Disaggregation of Revenue [Line Items]    
Total revenue 26,955 2,872
Milestone    
Disaggregation of Revenue [Line Items]    
Total revenue 2,825 1,008
Other    
Disaggregation of Revenue [Line Items]    
Total revenue 1,166 36
Calculated under Revenue Guidance in Effect before Topic 606 | Royalties    
Disaggregation of Revenue [Line Items]    
Total revenue 32,700 24,700
Calculated under Revenue Guidance in Effect before Topic 606 | Promacta    
Disaggregation of Revenue [Line Items]    
Total revenue 24,100 16,700
Calculated under Revenue Guidance in Effect before Topic 606 | Kyprolis    
Disaggregation of Revenue [Line Items]    
Total revenue 6,500 4,600
Calculated under Revenue Guidance in Effect before Topic 606 | Evomela    
Disaggregation of Revenue [Line Items]    
Total revenue 1,700 1,900
Calculated under Revenue Guidance in Effect before Topic 606 | Other    
Disaggregation of Revenue [Line Items]    
Total revenue $ 400 $ 1,100